274 related articles for article (PubMed ID: 21779787)
1. Quantitation of plasma circulating DNA using quantitative PCR for the detection of hepatocellular carcinoma.
Huang Z; Hua D; Hu Y; Cheng Z; Zhou X; Xie Q; Wang Q; Wang F; Du X; Zeng Y
Pathol Oncol Res; 2012 Apr; 18(2):271-6. PubMed ID: 21779787
[TBL] [Abstract][Full Text] [Related]
2. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
3. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
[TBL] [Abstract][Full Text] [Related]
4. Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study.
Zhao Q; Xu Y; Yuan D; Yang J; Wang Y; Shen G; Huang X
Dis Markers; 2021; 2021():9958909. PubMed ID: 34394775
[TBL] [Abstract][Full Text] [Related]
5. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma.
El-Shal AS; Zidan HE; Rashad NM; Wadea FM
Cytokine; 2017 Aug; 96():75-86. PubMed ID: 28371666
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
[TBL] [Abstract][Full Text] [Related]
9. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of alpha fetoprotein and HCCR-1, alone or in combination, in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Jirun P; Zhang G; Kim HK; Ha SA; Zhongtian J; Shishi Q; Zhuqingqing C; Lei G; Yoo J; Kim S; Park YG; Wang J; Yang Y; Xu Z; Huang Z; Lee YK; Song EY; Kim JW
Dis Markers; 2011; 30(6):307-15. PubMed ID: 21725159
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and Diagnostic Significance of SDPR-Cavin-2 in Hepatocellular Carcinoma.
Jing W; Luo P; Zhu M; Ai Q; Chai H; Tu J
Cell Physiol Biochem; 2016; 39(3):950-60. PubMed ID: 27513662
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
Chen L; Chu F; Cao Y; Shao J; Wang F
Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
[TBL] [Abstract][Full Text] [Related]
14. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
15. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
[TBL] [Abstract][Full Text] [Related]
17. Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.
Zhang ZQ; Meng H; Wang N; Liang LN; Liu LN; Lu SM; Luan Y
Diagn Pathol; 2014 Jul; 9():135. PubMed ID: 24993656
[TBL] [Abstract][Full Text] [Related]
18. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.
Xie Y; Yao Q; Butt AM; Guo J; Tian Z; Bao X; Li H; Meng Q; Lu J
Cancer Biol Ther; 2014 Sep; 15(9):1248-55. PubMed ID: 24971953
[TBL] [Abstract][Full Text] [Related]
19. DNA Methyltransferases as Potential Biomarkers for HCV Related Hepatocellular Carcinoma.
Hassouna MM; Naguib M; Radwan EM; Abdel-Samiee M; Estaphan S; Abdelsameea E
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3357-3363. PubMed ID: 33247696
[TBL] [Abstract][Full Text] [Related]
20. [A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].
Luo X; Wei YQ; Hai L; Hu YC; Zhao ZJ; Ma WL; Ma LN; Liu XY; Ding XC
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):505-510. PubMed ID: 31357775
[No Abstract] [Full Text] [Related]
[Next] [New Search]